Cisplatin cycles treatment sustains cardiovascular and renal damage involving TLR4 and NLRP3 pathways

• Κύριοι συγγραφείς: Antonio González (Συγγραφέας), Soledad García‐Gómez‐Heras (Συγγραφέας), Raquel Franco‐Rodríguez (Συγγραφέας), Visitación López‐Miranda (Συγγραφέας), Esperanza Herradón (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Wiley, 2023-08-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Abstract Cisplatin is clinically proven to combat different cancers, including sarcomas, soft tissue cancers, bones, muscles, and blood. However, renal and cardiovascular toxicities are important limitations in cisplatin therapeutical use. Immunoinflammation could be key factor in cisplatin‐induced...